Neurocrine Bioscience buy Wedbush
Start price
13.09.23
/
50%
€107.25
Target price
13.09.24
€127.63
Performance (%)
20.75%
Price
10:59
€129.50
Summary
This prediction is currently active. The prediction currently has a performance of 20.75%. This prediction currently runs until 13.09.24. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 0.577% | 0.577% |
| iShares Core DAX® | -0.051% | 4.829% |
| iShares Nasdaq 100 | 1.659% | 2.417% |
| iShares Nikkei 225® | 0.658% | -2.173% |
| iShares S&P 500 | 0.964% | 2.547% |
Comments by Wedbush for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Wedbush from $120.00 to $137.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat